186 related articles for article (PubMed ID: 20881002)
21. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.
Shin TH; Paterson AJ; Kudlow JE
Mol Cell Biol; 1995 Sep; 15(9):4694-701. PubMed ID: 7651386
[TBL] [Abstract][Full Text] [Related]
22. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
[TBL] [Abstract][Full Text] [Related]
23. Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.
Burnside J; Bernberg E; Anderson A; Lu C; Meyers BC; Green PJ; Jain N; Isaacs G; Morgan RW
J Virol; 2006 Sep; 80(17):8778-86. PubMed ID: 16912324
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
[TBL] [Abstract][Full Text] [Related]
25. Characterization of herpes simplex virus 2 primary microRNA Transcript regulation.
Tang S; Bosch-Marce M; Patel A; Margolis TP; Krause PR
J Virol; 2015 May; 89(9):4837-48. PubMed ID: 25673716
[TBL] [Abstract][Full Text] [Related]
26. Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoires.
Morin A; Bardot B; Simeonova I; Lejour V; Bouarich-Bourimi R; Toledo F
Transcription; 2013; 4(2):67-71. PubMed ID: 23412358
[TBL] [Abstract][Full Text] [Related]
27. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin.
Yang Y; Liu W; Ding R; Xiong L; Dou R; Zhang Y; Guo Z
PLoS One; 2016; 11(2):e0149227. PubMed ID: 26886852
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.
Bian J; Sun Y
Mol Cell Biol; 1997 Nov; 17(11):6330-8. PubMed ID: 9343394
[TBL] [Abstract][Full Text] [Related]
30. Modulation of microRNAs in two genetically disparate chicken lines showing different necrotic enteritis disease susceptibility.
Dinh H; Hong YH; Lillehoj HS
Vet Immunol Immunopathol; 2014 May; 159(1-2):74-82. PubMed ID: 24629767
[TBL] [Abstract][Full Text] [Related]
31. A microRNA component of the p53 tumour suppressor network.
He L; He X; Lim LP; de Stanchina E; Xuan Z; Liang Y; Xue W; Zender L; Magnus J; Ridzon D; Jackson AL; Linsley PS; Chen C; Lowe SW; Cleary MA; Hannon GJ
Nature; 2007 Jun; 447(7148):1130-4. PubMed ID: 17554337
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs, wild-type and mutant p53: more questions than answers.
Jones M; Lal A
RNA Biol; 2012 Jun; 9(6):781-91. PubMed ID: 22664917
[TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of murine p53 upstream sequences reveals additional positive transcriptional regulatory elements.
Reisman D; Eaton E; McMillin D; Doudican NA; Boggs K
Gene; 2001 Aug; 274(1-2):129-37. PubMed ID: 11675005
[TBL] [Abstract][Full Text] [Related]
34. Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.
Jarosinski KW; O'Connell PH; Schat KA
Virus Genes; 2003 May; 26(3):255-69. PubMed ID: 12876454
[TBL] [Abstract][Full Text] [Related]
35. p53 actions on microRNA expression and maturation pathway.
Suzuki HI; Miyazono K
Methods Mol Biol; 2013; 962():165-81. PubMed ID: 23150446
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
37. Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells.
Warnick CT; Dabbas B; Ford CD; Strait KA
J Biol Chem; 2001 Jul; 276(29):27363-70. PubMed ID: 11350971
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
39. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter.
Barroso-delJesus A; Romero-López C; Lucena-Aguilar G; Melen GJ; Sanchez L; Ligero G; Berzal-Herranz A; Menendez P
Mol Cell Biol; 2008 Nov; 28(21):6609-19. PubMed ID: 18725401
[TBL] [Abstract][Full Text] [Related]
40. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
